VEGF Release in Multiluminal Hydrogels Directs Angiogenesis from Adult Vasculature In Vitro

  • A. F. Dawood
  • P. Lotfi
  • S. N. Dash
  • S. K. Kona
  • K. T. Nguyen
  • Mario I. Romero-Ortega
Article

Abstract

Large bioengineered organs such as the heart and kidney need immediate perfusion by the host vascular network to avoid ischemia, support implant survival, and prevent implant failure. Vascularization of new bioengineered tissues can be stimulated by porous scaffold design and vascular growth factors. However, comprehensive vascularization of thick tissues in vitro remains a formidable challenge. We developed a simple and reproducible vascularization method that integrates a transparent biodegradable multiluminal scaffold for guided endothelial migration stimulated by intraluminal controlled release of Vascular Endothelial Growth Factor (VEGF). Two- and three-dimensional in vitro vasculogenesis induced by human umbilical vein endothelial cells (HUVEC)/fibroblast co-cultures formed discontinuous vessel-like structures. In sharp contrast, hydrogel microchannels with luminal collagen matrix, enticed the angiogenic growth from postnatal and adult aortic explants into the agarose microchannels, forming continuous vascular tubes identified by CD31 expression, in which the number of cells can be controlled by intraluminal VEGF concentration. This study suggests that multiluminal scaffolds can be used to promote angiogenesis from mature blood vessels and form vascular networks within thick bioengineered scaffolds. This method might offer a viable alternative in the prevascularization of bio-artificial organs.

Keywords

Vascularization Angiogenesis VEGF PLGA Microchannels 

References

  1. 1.
    Asahara, T., et al. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J. 18:3964–3972, 1999.CrossRefGoogle Scholar
  2. 2.
    Au, P., J. Tam, D. Fukumura, and R. K. Jain. Small blood vessel engineering. Methods Mol. Med. 140:183–195, 2007.CrossRefGoogle Scholar
  3. 3.
    Bahramsoltani, M., and J. Plendl. Different ways to antiangiogenesis by angiostatin and suramin, and quantitation of angiostatin-induced antiangiogenesis. APMIS 115:30, 2007.CrossRefGoogle Scholar
  4. 4.
    Bender, M., J. Bennett, R. Waddell, J. Doctor, and K. Marra. Multi-channeled biodegradable polymer/cultispher composite nerve guides. Biomaterials 25:1269–1278, 2004.CrossRefGoogle Scholar
  5. 5.
    Betsholtz, C., et al. Role of platelet-derived growth factor in mesangium development and vasculopathies: lessons from platelet-derived growth factor and platelet-derived growth factor receptor mutations in mice. Curr. Opin. Nephrol. Hypertens. 13:45, 2004.CrossRefGoogle Scholar
  6. 6.
    Cao, Y., et al. Human adipose tissue-derived stem cells differentiate into endothelial cells in vitro and improve postnatal neovascularization in vivo. Biochem. Biophys. Res. Commun. 332:370–379, 2005.CrossRefGoogle Scholar
  7. 7.
    Capla, J. M., et al. Skin graft vascularization involves precisely regulated regression and replacement of endothelial cells through both angiogenesis and vasculogenesis. Plast. Reconstr. Surg. 117:836–844, 2006.CrossRefGoogle Scholar
  8. 8.
    Chen, M., F. Zhang, and W. Lineaweaver. Luminal fillers in nerve conduits for peripheral nerve repair. Ann. Plast. Surg. 57:462, 2006.CrossRefGoogle Scholar
  9. 9.
    Clark, E., and E. Clark. Microscopic observations on the growth of blood capillaries in the living mammal. Am. J. Anat. 64:251–301, 1939.CrossRefGoogle Scholar
  10. 10.
    Dahl, S., C. Rhim, Y. Song, and L. Niklason. Mechanical properties and compositions of tissue engineered and native arteries. Ann. Biomed. Eng. 35:348–355, 2007.CrossRefGoogle Scholar
  11. 11.
    de Ruiter, G., et al. Methods for in vitro characterization of multichannel nerve tubes. J. Biomed. Mater. Res. A 84:643, 2008.Google Scholar
  12. 12.
    Frelin, C., A. Ladoux, and G. D’Angelo. Vascular endothelial growth factors and angiogenesis. Ann. Endocrinol. (Paris) 61:70–74, 2000.Google Scholar
  13. 13.
    Gafni, Y., et al. Design of a filamentous polymeric scaffold for in vivo guided angiogenesis. Tissue Eng. 12:3021–3034, 2006.CrossRefGoogle Scholar
  14. 14.
    Godbey, W., B. Stacey Hindy, M. Sherman, and A. Atala. A novel use of centrifugal force for cell seeding into porous scaffolds. Biomaterials 25:2799–2805, 2004.CrossRefGoogle Scholar
  15. 15.
    Hirschi, K., S. Rohovsky, L. Beck, S. Smith, and P. D’Amore. Endothelial cells modulate the proliferation of mural cell precursors via platelet-derived growth factor-bb and heterotypic cell contact. Circ. Res. 84:298, 1999.Google Scholar
  16. 16.
    Hirschi, K. K., T. C. Skalak, S. M. Peirce, and C. D. Little. Vascular assembly in natural and engineered tissues. Ann. N. Y. Acad. Sci. 961:223–242, 2002.CrossRefGoogle Scholar
  17. 17.
    Hutmacher, D. Scaffold design and fabrication technologies for engineering tissues state of the art and future perspectives. J. Biomater. Sci. Polym. Ed. 12:107–124, 2001.CrossRefGoogle Scholar
  18. 18.
    Invernici, G., et al. Human fetal aorta contains vascular progenitor cells capable of inducing vasculogenesis, angiogenesis, and myogenesis in vitro and in a murine model of peripheral ischemia. Am. J. Pathol. 170:1879–1892, 2007.CrossRefGoogle Scholar
  19. 19.
    Italiano, Jr., J., et al. Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet {alpha} granules and differentially released. Blood 111:1227, 2008.CrossRefGoogle Scholar
  20. 20.
    Iwasaki, K., et al. Bioengineered three-layered robust and elastic artery using hemodynamically-equivalent pulsatile bioreactor. Circulation 118:S52, 2008.CrossRefGoogle Scholar
  21. 21.
    Kaihara, S., et al. Silicon micromachining to tissue engineer branched vascular channels for liver fabrication. Tissue Eng. 6:105–117, 2000.CrossRefGoogle Scholar
  22. 22.
    Kim, B., A. Putnam, T. Kulik, and D. Mooney. Optimizing seeding and culture methods to engineer smooth muscle tissue on biodegradable polymer matrices. Biotechnol. Bioeng. 57:46–54, 1998.CrossRefGoogle Scholar
  23. 23.
    Ko, H. C., B. K. Milthorpe, and C.D. McFarland. Engineering thick tissues—the vascularisation problem. Eur. Cell Mater. 14:1–18, 2007; discussion 18-9.Google Scholar
  24. 24.
    Konig, G., et al. Mechanical properties of completely autologous human tissue engineered blood vessels compared to human saphenous vein and mammary artery. Biomaterials 30:1542–1550, 2009.CrossRefGoogle Scholar
  25. 25.
    Kopp, J., M. Jeschke, A. Bach, U. Kneser, and R. Horch. Applied tissue engineering in the closure of severe burns and chronic wounds using cultured human autologous keratinocytes in a natural fibrin matrix. Cell Tissue Banking 5:81–87, 2004.CrossRefGoogle Scholar
  26. 26.
    Larsen, A. Suramin: an anticancer drug with unique biological effects. Cancer Chemother. Pharmacol. 32:96–98, 1993.CrossRefGoogle Scholar
  27. 27.
    Matsusaki, M., H. Sakaguchi, T. Serizawa, and M. Akashi. Controlled release of vascular endothelial growth factor from alginate hydrogels nano-coated with polyelectrolyte multilayer films. J. Biomater. Sci. Polym. Ed. 18:775–783, 2007.CrossRefGoogle Scholar
  28. 28.
    Merks, R. M., S. V. Brodsky, M. S. Goligorksy, S. A. Newman, and J. A. Glazier. Cell elongation is key to in silico replication of in vitro vasculogenesis and subsequent remodeling. Dev. Biol. 289:44–54, 2006.CrossRefGoogle Scholar
  29. 29.
    Moon, J. H., et al. Isolation and characterization of multipotent human keloid-derived mesenchymal-like stem cells. Stem Cells Dev. 17:713–724, 2008.CrossRefGoogle Scholar
  30. 30.
    Moon, J. J., and J. L. West. Vascularization of engineered tissues: approaches to promote angio-genesis in biomaterials. Curr. Top. Med. Chem. 8:300–310, 2008.CrossRefGoogle Scholar
  31. 31.
    Nasseri, B., et al. Dynamic rotational seeding and cell culture system for vascular tube formation. Tissue Eng. 9:291–299, 2003.CrossRefGoogle Scholar
  32. 32.
    Nillesen, S., et al. Increased angiogenesis and blood vessel maturation in acellular collagen–heparin scaffolds containing both FGF2 and VEGF. Biomaterials 28:1123–1131, 2007.CrossRefGoogle Scholar
  33. 33.
    Norotte, C., F. Marga, L. Niklason, and G. Forgacs. Scaffold-free vascular tissue engineering using bioprinting. Biomaterials 30:5910–5917, 2009.CrossRefGoogle Scholar
  34. 34.
    Patel, Z., H. Ueda, M. Yamamoto, Y. Tabata, and A. Mikos. In vitro and in vivo release of vascular endothelial growth factor from gelatin microparticles and biodegradable composite scaffolds. Pharm. Res. 25:2370–2378, 2008.CrossRefGoogle Scholar
  35. 35.
    Perea, H., J. Aigner, U. Hopfner, and E. Wintermantel. Direct magnetic tubular cell seeding: A novel approach for vascular tissue engineering. Cells Tissues Organs 183:156–165, 2006.CrossRefGoogle Scholar
  36. 36.
    Pike, D., et al. Heparin-regulated release of growth factors in vitro and angiogenic response in vivo to implanted hyaluronan hydrogels containing VEGF and bFGF. Biomaterials 27:5242–5251, 2006.CrossRefGoogle Scholar
  37. 37.
    Priya, S. G., H. Jungvid, and A. Kumar. Skin tissue engineering for tissue repair and regeneration. Tissue Eng. Part B Rev. 14:105–118, 2008.CrossRefGoogle Scholar
  38. 38.
    Roberts, S., D. Howard, L. Buttery, and K. Shakesheff. Clinical applications of musculoskeletal tissue engineering. Br. Med. Bull. 86:7–22, 2008.CrossRefGoogle Scholar
  39. 39.
    Rocha, F., et al. The effect of sustained delivery of vascular endothelial growth factor on angiogenesis in tissue-engineered intestine. Biomaterials 29:2884–2890, 2008.CrossRefGoogle Scholar
  40. 40.
    Rouwkema, J., N. C. Rivron, and C. A. van Blitterswijk. Vascularization in tissue engineering. Trends Biotechnol. 26(8):431–441, 2008.CrossRefGoogle Scholar
  41. 41.
    Sachlos, E., D. Gotora, and J. Czernuszka. Collagen scaffolds reinforced with biomimetic composite nano-sized carbonate-substituted hydroxyapatite crystals and shaped by rapid prototyping to contain internal microchannels. Tissue Eng. 12:2479–2487, 2006.CrossRefGoogle Scholar
  42. 42.
    Shen, Y. H., M. S. Shoichet, and M. Radisic. Vascular endothelial growth factor immobilized in collagen scaffold promotes penetration and proliferation of endothelial cells. Acta Biomater. 4:477–489, 2008.CrossRefGoogle Scholar
  43. 43.
    Sieminski, A., R. Hebbel, and K. Gooch. The relative magnitudes of endothelial force generation and matrix stiffness modulate capillary morphogenesis in vitro. Exp. Cell Res. 297:574–584, 2004.CrossRefGoogle Scholar
  44. 44.
    Sodian, R., et al. Tissue-engineering bioreactors: a new combined cell-seeding and perfusion system for vascular tissue engineering. Tissue Eng. 8:863–870, 2002.CrossRefGoogle Scholar
  45. 45.
    Soker, S., S. Takashima, H. Miao, G. Neufeld, and M. Klagsbrun. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell 92:735–746, 1998.CrossRefGoogle Scholar
  46. 46.
    Tabata, Y., M. Miyao, M. Ozeki, and Y. Ikada. Controlled release of vascular endothelial growth factor by use of collagen hydrogels. J. Biomater. Sci. Polym. Ed. 11:915–930, 2000.CrossRefGoogle Scholar
  47. 47.
    Tan, W., and T. Desai. Microfluidic patterning of cells in extracellular matrix biopolymers: effects of channel size, cell type, and matrix composition on pattern integrity. Tissue Eng. 9:255–267, 2003.CrossRefGoogle Scholar
  48. 48.
    Vacanti, C. History of tissue engineering and a glimpse into its future. Tissue Eng. 12:1137–1142, 2006.CrossRefGoogle Scholar
  49. 49.
    Wendt, D., A. Marsano, M. Jakob, M. Heberer, and I. Martin. Oscillating perfusion of cell suspensions through three-dimensional scaffolds enhances cell seeding efficiency and uniformity. Biotechnol. Bioeng. 84:205–214, 2003.CrossRefGoogle Scholar
  50. 50.
    Wu, X., et al. Tissue-engineered microvessels on three-dimensional biodegradable scaffolds using human endothelial progenitor cells. Am. J. Physiol. Heart Circ. Physiol. 287:H480–H487, 2004.CrossRefGoogle Scholar
  51. 51.
    Yancopoulos, G., et al. Vascular-specific growth factors and blood vessel formation. Nature (London) 407:242–248, 2000.CrossRefGoogle Scholar
  52. 52.
    Yang, T., H. Miyoshi, and N. Ohshima. Novel cell immobilization method utilizing centrifugal force to achieve high-density hepatocyte culture in porous scaffold. J. Biomed. Mater. Res. 55:379–386, 2001.CrossRefGoogle Scholar
  53. 53.
    Yang, K., and A. Proweller. Vascular smooth muscle notch signals regulate endothelial cell sensitivity to angiogenic stimulation. J. Biol. Chem. 286(15):13741–13753, 2011.CrossRefGoogle Scholar
  54. 54.
    Zachary, I. Neuroprotective role of vascular endothelial growth factor: signalling mechanisms, biological function, and therapeutic potential. Neurosignals 14:207–221, 2005.CrossRefGoogle Scholar
  55. 55.
    Zengin, E., et al. Vascular wall resident progenitor cells: a source for postnatal vasculogenesis. Development 133:1543–1551, 2006.CrossRefGoogle Scholar

Copyright information

© Biomedical Engineering Society 2011

Authors and Affiliations

  • A. F. Dawood
    • 1
    • 2
  • P. Lotfi
    • 1
    • 2
  • S. N. Dash
    • 1
    • 2
  • S. K. Kona
    • 1
    • 2
  • K. T. Nguyen
    • 1
    • 2
  • Mario I. Romero-Ortega
    • 1
    • 2
  1. 1.Department of BioengineeringUniversity of Texas at ArlingtonArlingtonUSA
  2. 2.University of Texas Southwestern Medical CenterDallasUSA

Personalised recommendations